Additionally, myCAF (myofibroblastic MAF) clusters with distinguished ECM and TGFβ signaling signatures have been associated with primary resistance to immunotherapies in samples from non-responder melanoma patients (81). This evidence concerns the gene TGFB1 and melanoma.